National Research Management

Management criteria checks 4/4

National Research's CEO is Mike Hays, appointed in Jan 1981, has a tenure of 41.83 years. total yearly compensation is $217.09K, comprised of 58.7% salary and 41.3% bonuses, including company stock and options. directly owns 22.2% of the company’s shares, worth €198.36M. The average tenure of the management team and the board of directors is 8.8 years and 4.3 years respectively.

Key information

Mike Hays

Chief executive officer

US$217.1k

Total compensation

CEO salary percentage	58.7%
CEO tenure	41.8yrs
CEO ownership	22.2%
Management average tenure	8.8yrs
Board average tenure	4.3yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Mike Hays's remuneration changed compared to National Research's earnings?
Date	Total Compensation	Salary	Company Earnings
Sep 30 2022	n/a	n/a	US$35m
Jun 30 2022	n/a	n/a	US$36m
Mar 31 2022	n/a	n/a	US$37m
Dec 31 2021	US$217k	US$127k	US$37m
Sep 30 2021	n/a	n/a	US$36m
Jun 30 2021	n/a	n/a	US$36m
Mar 31 2021	n/a	n/a	US$35m
Dec 31 2020	US$255k	US$127k	US$37m
Sep 30 2020	n/a	n/a	US$38m
Jun 30 2020	n/a	n/a	US$36m
Mar 31 2020	n/a	n/a	US$36m
Dec 31 2019	US$234k	US$127k	US$32m
Sep 30 2019	n/a	n/a	US$31m
Jun 30 2019	n/a	n/a	US$30m
Mar 31 2019	n/a	n/a	US$31m
Dec 31 2018	US$289k	US$127k	US$30m
Sep 30 2018	n/a	n/a	US$29m
Jun 30 2018	n/a	n/a	US$26m
Mar 31 2018	n/a	n/a	US$24m
Dec 31 2017	US$236k	US$127k	US$23m
Sep 30 2017	n/a	n/a	US$22m
Jun 30 2017	n/a	n/a	US$23m
Mar 31 2017	n/a	n/a	US$21m
Dec 31 2016	US$248k	US$127k	US$20m
Sep 30 2016	n/a	n/a	US$21m
Jun 30 2016	n/a	n/a	US$20m
Mar 31 2016	n/a	n/a	US$19m
Dec 31 2015	US$189k	US$127k	US$17m

Compensation vs Market: Mike's total compensation ($USD217.09K) is below average for companies of similar size in the German market ($USD1.19M).

Compensation vs Earnings: Mike's compensation has been consistent with company performance over the past year.

CEO

Mike Hays (67 yo)

41.8yrs

Tenure

US$217,094

Compensation

Mr. Michael D. Hays, also known as Mike, serves as an Advisor of Picker Institute Inc. Mr. Hays founded National Research Corp. in 1981 and has been its Chief Executive Officer since 1981 and has been its...

Leadership Team

Name	Position	Tenure	Compensation	Ownership
Michael Hays	Founder	41.8yrs	US$217.09k	22.2% $ 198.4m
Kevin Karas	Senior VP of Finance	11.2yrs	US$482.55k	0.070% $ 626.3k
Jona Raasch	Chief Operating Officer	8.8yrs	US$506.15k	0.25% $ 2.2m
Helen Hrdy	Chief Growth Officer	2.8yrs	US$482.70k	0.16% $ 1.4m
Jon Boumstein	Chief Delivery Officer	1.5yrs	no data	no data
Gregory Makoul	Chief Transformation Officer	no data	no data	no data
Linda Stacy	Vice President of Finance	no data	no data	no data
Megan Charko	Senior Manager of Content Marketing	no data	no data	no data

8.8yrs

Average Tenure

63.5yo

Average Age

Experienced Management: NR1A's management team is seasoned and experienced (8.8 years average tenure).

Board Members

Name	Position	Tenure	Compensation	Ownership
Michael Hays	Founder	41.8yrs	US$217.09k	22.2% $ 198.4m
John Nunnelly	Lead Independent Director	24.9yrs	US$1.05m	0.11% $ 973.8k
Penny Wheeler	Independent Director	1.5yrs	US$231.25k	0% $ 0
Stephen Lockhart	Independent Director	1.5yrs	US$231.25k	0% $ 0
Donald Berwick	Independent Director	7.1yrs	US$150.01k	0% $ 0
Parul Bhandari	Director	less than a year	no data	no data

4.3yrs

Average Tenure

65yo

Average Age

Experienced Board: NR1A's board of directors are considered experienced (4.3 years average tenure).

National Research Management

Management criteria checks 4/4

Key information

Recent management updates

National Research Corporation, Annual General Meeting, May 08, 2024

Jennifer Baron Joins NRC Health as Its First Chief Experience Officer

National Research Corporation Announces the Retirement of Kevin Karas as Chief Financial Officer, Effective March 31, 2024

National Research Corporation Announces Executive Appointments

Founder recently sold €3.9m worth of stock

Founder recently sold €8.3m worth of stock

Recent updates

National Research Corporation to Report Q1, 2024 Results on May 07, 2024

National Research Corporation, Annual General Meeting, May 08, 2024

Jennifer Baron Joins NRC Health as Its First Chief Experience Officer

National Research Corporation Announces the Retirement of Kevin Karas as Chief Financial Officer, Effective March 31, 2024

National Research Corporation Declares Quarterly Cash Dividend, Payable on April 15, 2024

National Research Corporation to Report Q4, 2023 Results on Feb 13, 2024

National Research Corporation Announces Executive Appointments

National Research Corporation Declares Quarterly Dividend, Payable on January 12, 2024

National Research Corporation to Report Q3, 2023 Results on Nov 07, 2023

National Research Corporation Declares Special Dividend, Payable on September 22, 2023

National Research Corporation Declares Quarterly Dividend, Payable on October 13, 2023

National Research Corporation to Report Q2, 2023 Results on Aug 01, 2023

National Research Corporation Declares Quarterly Dividend, Payable on July 14, 2023

National Research Corporation Declares Quarterly Cash Dividend, Payable on April 14, 2023

National Research Corporation to Report Q4, 2022 Results on Feb 14, 2023

National Research Corporation Declares Quarterly Dividend, Payable on January 13, 2023

Founder recently sold €3.9m worth of stock

National Research Corporation Declares Quarterly Dividend, Payable on October 14, 2022

Now 21% undervalued

Second quarter 2022 earnings released: EPS: US$0.33 (vs US$0.35 in 2Q 2021)

Upcoming dividend of US$0.24 per share

Founder recently sold €8.3m worth of stock

National Research Corporation Announces Quarterly Dividend, Payable on July 15, 2022

National Research Corporation Announces Appointment to Board of Directors

First quarter 2022 earnings released: EPS: US$0.34 (vs US$0.36 in 1Q 2021)

Founder recently sold €129k worth of stock

Founder recently sold €129k worth of stock

Founder recently sold €304k worth of stock

National Research Corporation, Annual General Meeting, May 18, 2022

Upcoming dividend of US$0.24 per share

National Research Corporation Declares Quarterly Dividend, Payable on April 15, 2022

Full year 2021 earnings: EPS in line with analyst expectations despite revenue beat

Founder recently sold €191k worth of stock

Upcoming dividend of US$0.12 per share

Founder recently sold €2.4m worth of stock

Founder recently sold €333k worth of stock

Founder recently sold €2.2m worth of stock

Third quarter 2021 earnings released: EPS US$0.38 (vs US$0.38 in 3Q 2020)

Upcoming dividend of US$0.12 per share

Founder recently sold €176k worth of stock

Senior VP of Finance recently sold €226k worth of stock

Second quarter 2021 earnings released: EPS US$0.35 (vs US$0.31 in 2Q 2020)

Upcoming dividend of US$0.12 per share

Founder recently sold €474k worth of stock

First quarter 2021 earnings released: EPS US$0.36 (vs US$0.47 in 1Q 2020)

Founder recently sold €3.3m worth of stock

Founder recently sold €203m worth of stock

Founder recently sold €2.6m worth of stock

Full year 2020 earnings released: EPS US$1.48 (vs US$1.30 in FY 2019)

New 90-day high: €43.20

Independent Director recently sold €209k worth of stock

Full year 2020 earnings released: EPS US$1.48 (vs US$1.30 in FY 2019)

New 90-day low: €37.60

Independent Director recently sold €1.7m worth of stock

New 90-day high: €47.60

National Research Corporation Announces Executive Changes

Third quarter 2020 earnings released: EPS US$0.38

President recently sold €246k worth of stock

New 90-day low: €42.60

President recently sold €244.5k worth of stock

New 90-day low - €44.40

First half earnings released

National Research Corporation Announces Not to Pay a Dividend for the Current Quarter

National Research Corporation to Report Q2, 2020 Results on Aug 04, 2020

CEO Compensation Analysis

CEO

Tenure

Compensation

Leadership Team